US equities |
MU $694.86 ▲+5.86% NVDA $188.15 ▲+3.60% AMD $444.05 ▲+9.80% SNDK $842.57 ▲+4.48% TSLA $361.65 ▲+5.23% SPCX $131.32 ▲+6.23% AAPL $343.99 ▼-0.05% MSFT $535.86 ▼-0.01%
FinancialContent

Profound Medical Corp. - common stock (NQ:PROF)

6.960 +0.080 (+1.16%)
Delayed Quote Updated: 11:46 AM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Profound Medical Corp. - common stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Profound Medical (PROF) Q3 2026 Earnings Call Transcript ↗
Revenue surged on system placements while a leadership transition reshapes the company's top job. 
Via The Motley Fool
Topics Earnings
News headline image
Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
Patient advocacy initiative expands its reach with a nationally recognized voice on health, resilience and informed treatment decisions 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
From Profound Medical Corp.
Via GlobeNewswire
Top stock movements in today's session. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Thursday's pre-market session: top gainers and losers ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to 47% 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA Procedures™ per system per day 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Management Change
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical (PROF) Q2 2026 Earnings Call Transcript ↗
Record orders and expanding payer coverage mark commercial inflection. 
Via The Motley Fool
Topics Earnings
News headline image
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
A patient-centered initiative focused on education, connection, and support 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Q2 Earnings Call Highlights ↗
Profound Medical (NASDAQ:PROF) reported second-quarter 2026 revenue of CAD 2.5 million, up 12% from CAD 2.2 million a year earlier, as the company said the reported figure was affected by the timing of... 
Via MarketBeat
Topics Earnings
News headline image
Profound Medical Reports Second Quarter 2026 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
– Whole-gland TULSA ablation demonstrates statistically significant superior penile length preservation compared to robotic RP at 1 month – 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Q1 Earnings Call Highlights ↗
Profound Medical (NASDAQ:PROF) reported sharply higher first-quarter revenue and reiterated its view that adoption of its TULSA prostate treatment platform is moving toward broader commercial use,... 
Via MarketBeat
Topics Earnings
News headline image
Profound Medical Reports Strong First Quarter 2026 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
News headline image
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
From Profound Medical Corp.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >